Journal of Veterinary Pharmacology and Therapeutics

Papers
(The median citation count of Journal of Veterinary Pharmacology and Therapeutics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Depletion of dexamethasone in cattle: Food safety study in dairy and beef cattle18
Pharmacokinetics of meloxicam in pre‐ruminant calves after intravenous, oral, and subcutaneous administration16
Pharmacokinetics of diphenhydramine following single‐dose intravenous and oral administration in non‐fasted adult horses12
The history and pharmacology of buprenorphine: New advances in cats12
Assessment of verdinexor as a canine P‐glycoprotein substrate12
Pharmacokinetics of fluoxetine in horses following oral administration12
11
Issue Information11
Effects of acaricides on the activities of monooxygenases in bovine liver microsomes11
Margin of safety of extended‐duration transdermal buprenorphine solution following multiple‐dose administrations to cats11
Issue Information10
Folke Rasmussen: An appreciation10
Issue Information10
O108 | Red orange and lemon extract ameliorates the renal toxicity effect induced by Ochratoxin A through the modulation of ROS accumulation and NF‐kB signaling9
Letter to the Editor regarding “The publication of studies involving the use of human critically important antimicrobial agents in veterinary species”9
O58 | A versatile extraction and purification method for ivermectin detection through HPLC and LC/MS in feed, water, feces, soil, and sewage9
Letter to the Editor regarding ‘The publication of studies involving the use of human critically important antimicrobial agents in veterinary species’9
O59 | Breakthrough: A first‐in‐class virtual simulator for dose optimization of ACE inhibitors in veterinary cardiology8
Introduction8
P82 | Multiclass screening method to detect banned substances in urine by LCMS/MS7
P44 | Antimicrobial activity of essential oils extracted from Origanum vulgare and Melaleuca armillaris against Escherichia coli isolated from poultry feces7
P87 | Antibacterial drug residues in animal tissues for human consumption: Monitoring and exposure assessment7
I2 | The availability and use of antimicrobial agents7
O71 | Pharmacokinetics of macrocyclic lactones endectocide in indigenous zebu cattle and its insecticidal efficacy on Anopheles arabiensis6
I19 | Ghent University's Veterinary Oncology Network: Towards solutions for human and veterinary cancer patients6
O41 | Regenerative medicine for the treatment of pharmacoresistant epilepsy?6
O52 | RNAseq characterization of transcriptional biomarkers related to testosterone esters administration in fattening pigs6
P14 | Antibiofilm effect of plant extracts6
I6 | Biosecurity in animal production to improve health and reduce antimicrobial use5
O85 | Antibacterial activity of propyl gallate in combination with orbifloxacinagainst E. coli in an in vitro pharmacodynamic model5
P11 | Synovial and systemic pharmacokinetics of florfenicol in pigs5
P79 | Development of analytical method for veterinary drugs in honey using LCMS/MS and GCMS/MS5
O67 | Differences between global, European, and Dutch categorization of antibiotics for veterinary use: What would be the consequences of alignment?5
P35 | The pharmacokinetics of gallic acid in finisher broilers5
O79 | Toxicity of individual and binary mixtures of perfluoroalkyl compounds in freshwater algae Raphidocelis subcapitata5
P12 | Antibacterial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis isolated from pigs in Hungary, 2018–20215
P42 | Teat dip disinfectant formulation for dairy cows based on Melaleuca armillaris essential oil5
Author Index5
O96 | The use of zinc‐chloride coated splints in biofilm prevention following septoplasty5
P9 | Pharmacokinetics of lincomycin in laying hens and its residue profiles in egg and plasma5
O26 | PK/PD informed dosage regimen for antimicrobial prophylaxis in companion animal surgery: From proof of concept to pipeline5
O20 | The effect of ATR kinase inhibition on chlorambucil activity against canine lymphoma and leukemia cell lines5
I29 | The global problem of pharmaceutical pollution5
I17 | Gene editing and gene therapy: Perspectives for the future of veterinary medicine in the ‘CRISPR era’4
O39 | Effects of flunixin meglumine on the systemic inflammatory response to intravenous lipopolysaccharide in horses4
P19 | Determination of optimal ratios for three sulfonamides/trimethoprim combinations against E. coli using checkerboard and time‐kill assays4
Pharmacokinetics and Physiological Effects of a Single Oral Dose of Oxycodone in Healthy Dogs: A Pilot Study4
O64 | PK/PD based dose optimization of enrofloxacin in combination with sulfamethoxazole/ trimethoprim against Pasteurella multocida in pigs4
O82 | Homogeneity, stability, interactions, and cross‐contamination of antibacterial drugs mixed into drinking water for group treatment in broilers4
Sodium‐glucose transport protein 2 inhibitor use in the management of insulin dysregulation in ponies and horses4
4
O91 | Pharmacokinetics and therapeutic efficacy of liposomal cannabidiol (CBD) injection: A pilot clinical study in dogs with naturally‐occurring osteoarthritis4
P83 | Limits of the limits in the food and feed safety4
Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus)4
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?4
Examination of the pharmacokinetics and differential inhibition of cyclooxygenase isoenzymes in New Zealand white rabbits (Oryctolagus cuniculus) by the Non‐Steroidal anti‐inflammato4
Pharmacokinetics and pharmacodynamics of doxycycline in aStreptococcusequisubsp.zooepidemicusinfection model in horses3
Detection times of clodronic acid in horses with orthopedic disease3
Pharmacokinetics of meloxicam in laying hens after single intravenous, oral, and intramuscular administration3
The pharmacokinetic characteristics of sulfadiazine in channel catfish (Ictalurus punctatus) following oral and intravenous administrations3
Safety of torasemide in healthy adult dogs administered daily for 26 weeks3
Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial3
Pharmacokinetics of oral clonazepam in growing commercial pigs (Sus scrofa domestica)3
Pharmacokinetics of furosemide in goats following intravenous, intramuscular, and subcutaneous administrations3
Depletion of tilmicosin residue in Gushi chickens following oral administration via drinking water3
Erratum3
Determination of colistin in luminal and parietal intestinal matrices of chicken by ultra‐high‐performance liquid chromatography‐tandem mass spectrometry3
Residue Behavior and Risk Assessment of Diazepam and Its Metabolites in Crucian Carp (Carassius auratus) After Oral Administration3
Pharmacokinetics of meloxicam following intravenous administration at different doses in sheep3
Control of ticks on horses using abamectin‐impregnated ear tags. A pharmacokinetic and pharmacodynamic study3
Pharmacokinetics of oral and compounded intravenous gabapentin in Duroc swine (SusScrofa)3
Detection and Analysis of Florfenicol Residues and Metabolites in Nile Tilapia (Oreochromis niloticus) Tissues Post‐Oral Administration in Tropical Waters3
Pharmacokinetic evaluation of oral deracoxib in geese (Anser anser domesticus)3
Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii)3
Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1‐1Δ3
Pseudomonas aeruginosasusceptibility, antibiogram and clinical interpretation, and antimicrobial prescribing behaviors for dogs with otitis in the Midwestern United States3
Pharmacokinetics of tilmicosin in plasma, urine and feces after a single intragastric administration in donkey (Equus asinus)3
Effect of ketoprofen on intravenous pharmacokinetics of ganciclovir in chukar partridges (Alectoris chukar)3
Development and application of a physiologically based pharmacokinetic model for orbifloxacin in crucian carp (Carassius auratus)3
Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine2
P94 | Molluscicide exposures among dogs: A 2022 annual overview of calls to the Belgian Poison Centre2
Determination of temporal changes in hepatic drug‐oxidizing capacity using plasma metabolite/caffeine ratios in non‐pregnant and pregnant goats2
O43 | Integrity of data (ALCOA) and uncertainty: How derivate the uncertainty from analytical validation method and how interpolate it on the validated interval?2
Issue Information2
I35 | Phytotherapy and nanotechnology advances against bacterial resistance in veterinary medicine2
Effects of starvation on the pharmacokinetics and optimal dosages of florfenicol and associated serum biochemistry in Asian seabass (Lates calcarifer)2
PK/PD modelling of enrofloxacin againstGlaesserella parasuisinfection in pigs2
Plasma concentrations of diclazuril following oral administration of diclazuril and diclazuril sodium salt to cattle2
O95 | In vitro and ex vivo antibacterial effects of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits2
O75 | Pharmacodynamic and phenotypic evaluation of eprinomectin resistant Haemonchus isolates from French dairy sheep farms2
P98 | Utility of the micro‐blood sampling (drug blood spot) technique for pharmacokinetic studies2
O78 | Evaluation of the difference in contamination by per‐ and poly‐fluorinated substances (PFASs) in wild boar and swine tissues sampled in the same area2
Letter to the editor2
P26 | Astaxanthin as an effective modulator of drug‐induced oxidative stress: A rat model2
Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats2
P21 | Prudent use of antimicrobials in cats at the veterinary teaching hospital of the university of Pisa, Italy2
Biosafety and Withdrawal Period of In‐Feed Administered Antiparasitic Drug Emamectin Benzoate in Cirrhinus mrigala (Hamilton, 1822)2
Doxycycline pharmacokinetics and tissue depletion in striped catfish (Pagasianodon hypophthalmus) after oral administration2
O72 | Pharmacokinetics of long‐acting ampicillin in rhesus macaques (Macaca mulatta)2
P84 | Uptake of oxytetracycline by lettuce fertilized with broiler litter2
P20 | Antimicrobial prescribing practice at three equine veterinary teaching hospitals in Italy2
P2 | Doxycycline pharmacokinetics in chickens with experimental Mycoplasma gallisepticum infection2
Disposition kinetics of meloxicam in green sea turtles (Chelonia mydas) after intravenous and intramuscular administrations2
O93 | Possible reduction in lameness after oral administration of cannabinoids to chronically lame horses2
O68 | How taking into account the drinking behavior of piglets can improve antibiotic treatment via drinking water2
P41 | Mycotoxins and endotoxins binding by an innovative anti‐mycotoxins agent2
Using simulations to explore the potential effect of disease and inflammation on the frequency of violative flunixin residues in cattle2
Doxycycline serum protein binding in pigs reveals a relatively high free fraction2
O27 | Flea resistance to fipronil: Confirmation of metabolic detoxification through innovative HPLC dosage within fleas2
O45 | Pharmacokinetics and effects of codeine in combination with acetaminophen on thermal nociception in horses2
O60 | Comparison of intestinal barrier integrity in conventional 2D cell lines and canine duodenal enteroids2
O15 | Melaleuca armillaris nanoencapsulated against methicillin resistant Staphylococcus aureus2
Pharmacokinetics of danofloxacin after single oral and intravenous administration in non‐laying hens1
P33 | Whole transcriptome analysis of plant‐based feed additive treated Brachyspira hyodysenteriae1
I16 | Virus‐free engineering of CAR‐T cell therapy for companion canines1
P86 | Fipronil administration in laying hens: Edible and inedible tissue residue profiles1
P58 | Resistance of ivermectin 1% injectable in standard, double and triple doses in calves artificially infested with isolate of C. hominivorax and confirmation in vitro tests with first (1
In vivo joint synovial fluid disposition of a novel sustained‐release formulation of diclofenac and hyaluronic acid in horses1
P8 | Pharmacokinetics of long‐acting formulation of amoxicillin trihydrate in dogs after intramuscular injection1
In Situ Uterine Artery Prostaglandin E2 and Nitric Oxide in Open‐Cervix Pyometra and Medically Treated Bitches1
P32 | Methane production and performance in dairy cows fed with RumenProof CF1
1
Corrigendum1
Issue Information1
Issue Information1
I31 | Advanced in vitro models and whole organ engineering in veterinary medicine using organoids1
Comparative disposition kinetics of oral deracoxib in sheep and goats1
P50 | Abundance and diversity of the fecal resistome in small‐holder broiler systems in Kenya1
Metronidazole pharmacokinetics in geese (Anser anser domesticus) after intravenous and oral administrations1
P70 | Limited market applications in the EU: Experiences under regulation EU 2019/61
Issue Information1
P56 | The anti‐inflammatory and immunomodulating activity of novel standardized propolis extract (SPE) for veterinary and human medicinal use1
P30 | Beneficial effect of fermented wheat germ extract in intestinal epithelial cells in case of lipopolysaccharide‐evoked inflammation1
O101 | Whole‐transcriptomic effects of bentonite, when used to prevent aflatoxin B1 toxicity, on a widely used in vitro model of intestinal epithelium1
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib1
Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats1
O107 | Unveiling the role of bovine CYP1A1 and CYP3A28 in AFB1 metabolism: Molecular docking and CRISPR/Cas9‐mediated genetic knockout in BFH12 cells1
Pharmacokinetics and Alterations in Glucose and Insulin Levels After a Single Dose of Canagliflozin in Healthy Icelandic Horses1
O51 | Algal extracts as potential anticancer agents: Preliminary investigations in C2 canine mastocytoma cell line1
1
1
Pharmacokinetic Profiles of Metamizole Metabolites after Intramuscular and Intravenous Administration in Healthy Arabian Horses1
Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration1
Metabolism and residue differences of Enrofloxacin between the brain and peripheral tissues and the resulting brain damages in crucian carp (Carassius auratus var. Pengze)1
Issue Information1
P92 | Hybrid practical training in veterinary pharmacology learning at veterinary school Oniris, France1
Comparison of an injectable toltrazuril–gleptoferron and an oral toltrazuril + injectable gleptoferron in piglets: Hematinic activities and pharmacokinetics1
O47 | Robenacoxib pharmacokinetics in goats (Capra hircus) following single oral, subcutaneous and intravenous administration1
Pharmacokinetic characteristics of danofloxacin in green sea (Chelonia mydas) and hawksbill sea (Eretmochelys imbricata) turtles1
P45 | Antimicrobial susceptibility profiles of Staphylococcus aureus and coagulase negative staphylococcus from subclinical mastitis in goat dairy farms1
Pharmacokinetics of dipyrone in horses: A multi‐dose, dose escalation study1
Single‐dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in cats1
Doxycycline pharmacokinetics in geese1
O111 | Population PK modeling of different sulfonamides in association with trimethoprim in pigs1
P18 | Pharmacokinetics of tiamulin in geese after single and multiple oral administrations and evaluation of drug effects on resistance in cloacal flora1
Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep1
Pharmacokinetics and pharmacodynamics of intravenous and oral apixaban in horses1
Pharmacokinetics of carprofen following single and repeated intravenous administrations of different doses in sheep1
The Vehicle of Administration and Prandial State May Reduce the Spectrum of Oral Broad‐Spectrum Antibiotics (Oxytetracycline, Fosfomycin and Amoxicillin) Administered to Piglets: A Pharmacokinetic/Pha1
Pharmacokinetics and effects of codeine in combination with acetaminophen on thermal nociception in horses1
Oral pharmacokinetic profile of fipronil and efficacy against flea and tick in dogs1
O100 | Evaluation of the oxidoreductive balance in wild boars (Sus scrofa) contaminated by Zearalenone (ZEN)1
Potential for extending the chloramphenicol dosing interval for canine urinary tract infections1
O105 | The European partnership for the assessment of risk from chemicals (PARC): Its aims and expected impacts1
O36 | Assessment of the antinociceptive efficacy of analgesics, anesthetics and other compounds in zebrafish (Danio rerio)0
P100 | Drug interactions in small animal veterinary medicine: Survey results from 1014 veterinary practitioners0
P7 | Valnemulin misuse in medicated feed for rabbit: Possible route for antimicrobial resistance spread0
P99 | Suspected malicious wildlife poisoning in North‐Western Italy: A 2014–2022 survey0
O86 | Combination of antibiotic and bacteriophages to prevent the selection of resistant Pseudomonas aeruginosa0
Pharmacokinetics and residue elimination of norfloxacin in rainbow trout (Oncorhynchus mykiss)0
Multicentered masked placebo‐controlled phase 2 clinical study of an extended duration transdermal buprenorphine solution for postoperative pain in cats0
O112 | On the edge of equine atypical myopathy: A first large‐scale report of subclinical Hypoglycin A poisoning in horses0
Pharmacokinetics of toltrazuril and its metabolite, toltrazuril sulfone, in suckling piglets following oral and intramuscular administrations0
Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL‐31‐induced pruritus0
P65 | A physiologically based kinetic model to measure welfare in animals using stress biomarkers as part of the TKPlate 2.0 project0
Population Pharmacokinetics of Enrofloxacin in Ctenopharyngodon idella Based on the Sparse Sampling Method and a Nonlinear Mixed Effect Model Following Intravenous and Oral Administration0
Pharmacokinetic profiles of three dose rates of morphine sulfate following single intravenous, intramuscular, and subcutaneous administration in the goat0
I33 | Cannabinoids and their medicinal use in man and animals0
Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses0
Multidose pharmacokinetics and safety of a modified, compounded theophylline product in dogs0
O103 | The effect of canagliflozin on blood glucose and insulin in healthy standardbred horses0
Co‐formulation of ketoprofen with tulathromycin alters pharmacokinetic and pharmacodynamic profile of ketoprofen in cattle0
Issue Information0
Pharmacokinetic characteristics of azithromycin in freshwater crocodiles (Crocodylus siamensis) after intramuscular administration at three different dosages0
Safety of the Selective JAK1 Inhibitor Oclacitinib in Dogs0
Pharmacokinetic report: Pharmacokinetics of a single oral dose of gabapentin in goats (Capra hircus)0
Plasma pharmacokinetics of clorsulon following administration of a single subcutaneous or intravenous injection to cattle0
P22 | Prevalence of MRSA in companion animals from 2019 to 2021 in Germany0
O23 | Anti‐tumor effect of trametinib in canine primary lung cancer organoids as a novel therapeutic agent0
Pharmacokinetics of letrozole and effects of its increasing doses on gonadotropins in ewes during the breeding season0
O55 | Risk of residues of toltrazuril sulfone in eggs after oral administration0
P72 | Metals occurrence in eagle and goshawks from Northwestern Italy0
P90 | Differential breed‐, age‐ and sex‐regulated muscarinic receptor distribution in atria and ventricles of turkeys0
I25 | Reassessment of class D antimicrobials of the AMEG classification: What data needs to be generated for optimal use of old antibiotics?0
Pharmacokinetics and pharmacokinetic interactions of orally administered oxfendazole and oxyclozanide tablet formulation to sheep0
O9 | Antibiotic tissue penetration in the septic piglet versus the child – Lessons learnt from microdialysis0
P85 | Residue depletion of enrofloxacin and flumequine in feathers of broilers based on quantitative UHPLCMS/MS detection0
O62 | Population pharmacokinetics of sodium salicylate in chickens and turkeys – New insights into the drug's non‐linear elimination0
Professor Christian Friis: An appreciation0
0
I34 | The question of mycotoxins: Overview and current issues0
Analysis of US Marketed Artemisinin Supplements for Use in Dogs0
The Single‐Dose Pharmacokinetics of a Compounded Levetiracetam Formulation and Bioequivalence to a Commercial Formulation in Healthy Dogs0
O66 | Milking related milk volume changes: Implementation in a physiologically based kinetic lactation model0
P71 | Regulation (EU) 2021‐805 amending annex II to regulation (EU) 2019/6: Challenges for R&D0
Issue Information0
O110 | Dose‐dependent impact of enrofloxacin on broiler chicken gut resistome is mitigated by synbiotic application0
Pharmacokinetics of thiamine (vitamin B1) in adult horses after administration of three single intravenous doses0
Can diarrhea affect the pharmacokinetics of racecadotril in neonatal calves?0
Comparison of oral, nebulized and combination antibiotic treatment ofBordetellabronchisepticain baboons (Papiospp.)0
PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli0
Cytochrome P450 reaction phenotyping of itraconazole hydroxylation in the dog0
Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control0
The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo0
I26 | Role of clinical microbiology services in monitoring emerging resistances in small animals and their hospital environment0
I28 | Next generation saRNA vaccines for rapid response to infectious disease outbreaks0
Pharmacokinetics, withdrawal period and risk assessment of enrofloxacin in the northern snakehead (Channa argus) following bath administration0
0
P88 | Altered endothelial function in response to high glucose level in the isolated thoracic aorta of Sprague–Dawley rats: A study of the effect of gliflozins0
0
O25 | Whole transcriptome analysis of Clostridium perfringens treated with a plant‐based feed additive0
P80 | Multi‐class determination of 60 antibiotic residues in milk by LCMS/MS0
I24 | Update on the ENOVAT guideline for surgical prophylaxis and peri‐operative use0
I36 | The first extensive bio‐monitoring mycotoxin exposure survey in livestock animals reveals significant exposure to multi‐mycotoxins0
Pharmacokinetics and therapeutic efficacies of fenbendazole in comparison with levamisole in helminth‐infected Caspian turtles (Mauremys caspica)0
O57 | Three‐years monitoring of glyphosate residues in honey from Lombardy and Emilia‐Romagna regions, Italy: Preliminary results0
P47 | Monitoring of veterinary antimicrobials sales data as a part of one health approach on combating antimicrobial resistance0
P29 | Bovine milk casein diet supplementation reduce Cd level in liver and kidney of cadmium intoxicated rats0
Letter to the Editor regarding “The publication of studies involving the use of human critically important antimicrobial agents in veterinary species”0
Population pharmacokinetics of butorphanol following intramuscular administration to exercised thoroughbred horses0
O92 | Liposomal cannabidiol (CBD) injection: A novel therapeutic formulation is on the horizon0
Correspondence on Analysis of US Marketed Artemisinin Supplements for Use in Dogs0
Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration0
P15 | Modulation of the acute inflammatory response induced by the Escherichia coli lipopolysaccharide by the interaction of FFC and PTX0
Issue Information0
0
P38 | Histopathological features in selected organs of turkeys experimentally exposed to low doses of salinomycin – Preliminary study0
Pharmacokinetics of glaucine after intravenous and oral administrations and detection of systemic aporphine alkaloids after ingestion of tulip poplar shavings in horses0
Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)0
The effects of food on the pharmacokinetics of mycophenolate mofetil in healthy horses0
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygousMDR1‐deficient collie dogs0
Pharmacokinetics, Tissue Residues, and Withdrawal Times of Florfenicol in Chukar Partridges (Alectoris chukar)0
Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs (Sus scrofa domestica)0
The Pharmacokinetics of Subcutaneous Eprinomectin in Plasma and Milk in Dry Dairy Cattle0
O24 | In vitro porcine intestinal co‐culture model to test antimicrobial alternatives in Escherichia coli and Salmonella enterica infection0
O102 | Biotransformation as an effective strategy to recover performance of broiler chickens fed diets naturally contaminated diet by Fumonisins (FUM) and Deoxynivalenol (DON)0
Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs0
P36 | Adapted minimal inhibitory concentration testing protocol as screening tool for gut health and related products0
Influence of Escherichia coli endotoxemia on danofloxacin pharmacokinetics in broilers following single oral administration0
P55 | Robenacoxib pharmacokinetics in geese (Anser anser domesticus) following single intravenous and oral administration0
0.1409158706665